Goldman Sachs analyst Terence Flynn initiates coverage on Bristol-Myers Squibb Co. (NYSE: BMY) with a Buy rating and a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot New Coverage New Coverage